Navigation Links
Alcoholism Drug Fails To Prevent Drinking Relapses

The Food and Drug Administration approved naltrexone for the treatment of alcoholism in 1994. At that time, the only other drug therapy available was disulfiram, or Antabuse, which provokes a sickening reaction to alcohol.// A new study casts sobering doubts on earlier claims that an alcoholism drug can truly treat the addiction.

The government is sponsoring a large trial comparing naltrexone, which is also used to treat heroin addiction, with another alcoholism drug, acamprosate. Both medications act on the brain's opioid receptors to make drinking less pleasurable.

Earlier studies, including the work that led to its FDA approval, showed that when combined with counseling naltrexone could help control alcoholism by reducing drinking days and increasing days without liquor. The drug was also shown to suppress cravings and prevent relapses. In fact, the latest study was intended to learn not whether the drug was effective, which was assumed, but for how long. The study says naltrexone fails to prevent drinking relapses, and in fact is no better than sugar pills at keeping hardened alcoholics on the wagon.
'"/>




Page: 1

Related medicine news :

1. Alcoholism Influenced By Both Genetics & Family Environment
2. Detrimental Effect Of Chronic Alcoholism On Male Fertility
3. Smoking And Its Relation To Neurocognitive Deficits In Alcoholism
4. Alcoholism Linked To Higher Death Rates Among Older Men
5. Alcoholism Drug Vivitrol Approved By FDA
6. Is Alcoholism Genetic?
7. Alcoholism & Dependence Seen More Commonly In Early Alcohol Drinkers
8. Study to Identify People at Risk of Alcoholism
9. Mother’s Drinking May Increase Childs Alcoholism Ris
10. Good drinkers have Higher Risk of Alcoholism
11. Effective Cure for Alcoholism – A single dose of LS
Post Your Comments:
(Date:5/22/2008)..., N.C. -- A new study by Duke University researche...O) system in the life of a cell plays a key role i...ve treatment of illnesses such as heart disease an...a major biological signaling pathway that has been...s, and it is linked to cancer and other diseases w...
(Date:5/22/2008)...entation Will be Webcast Live and Archived on Comp...-FirstCall/ -- Vanda Pharmaceuticals,Inc. (Nasdaq:...he development,and commercialization of clinical-s... disorders, today announced that Mihael H. Polymer...r a corporate presentation on,Wednesday, May 28, 2...
(Date:5/22/2008)... BEACH, Calif., May 22 /PRNewswire/ -- Whether you... short getaway, if you are an older adult,there ar...re a healthy,trip. According to Timothy Schwab, M....se ten tips for seniors apply whether you,re plann...s away., 1. Discuss travel plans with your ...
(Date:5/22/2008)...udy suggests threat of starvation triggers the swi...) -- New animal research suggests the body,s biolo... the rise and fall of the sun, can be overridden i..., The finding is based on work with mice and ha...cations are that, when faced with starvation, the ...
Breaking Medicine News(10 mins):Health News:Major 'missed' biochemical pathway emerges as important in virtually all cells 2Health News:Major 'missed' biochemical pathway emerges as important in virtually all cells 3Health News:Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference 2Health News:SCAN Health Plan Offers Seniors Ten Tips for Safe and Healthy Travel 2Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 2Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 3Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 4
...ernational research consortium investigating the g...s has identified a new genetic risk factor for coe...fering from coeliac disease lack a protective DNA ...n, otherwise found in healthy individuals. Behind...
...ing to a research abstract that will be presented ...sorder among infants and toddlers born prematurel... and at higher rates than among full-term infants....ontgomery-Downs, PhD, of West Virginia University,...
...orts are to be believed, then the "medical conditi...jail early, only to be thrown back inside a day l...ed infection. According to the News of the World ...I, and it is such a "severe problem" that Sheriff ...
...ocumented first -of -its-kind case, a teenager die...he aching muscles. Arielle Newman, 17, from Stat... surprisingly high amount of methyl salicylate, th...eams, was discovered in her body. Various compan...
Other Medicine News:Health News:Genetic Risk Factor for Coeliac Disease Identified. 2Health News:Paris' 'medical Condition' is a Sexually Transmitted Infection 2Health News:American Sports Star Teenager Dies Due To Overdose Of Muscle Cream 2
(Date:5/22/2008)...didate, RDEA806, Demonstrated No Reproductive Toxi... -, - RDEA427 Selected as Clinical Candidate, Demo...ential for Once Daily Oral Dosing -, SAN DIEGO, M... Inc.,(Nasdaq: RDEA ) today announced preclinical...tase inhibitor (NNRTI) candidate, RDEA806, demonst...
(Date:5/21/2008)...derscore the Utility of CAPHOSOL in Treating Oral ...- New data show that CAPHOSOL(R), (http://www.caph...eves painful oral,mucositis (OM) and improves qual...erapy and radiation therapy. These data were repor... 33rd Annual Congress of the,Oncology Nursing Soci...
(Date:5/21/2008)...nted at 12th World Congress on the Menopause show ...yspareunia, two of the most frequent s... ARBOR, Mich., May 21 /- QuatRx Pharm...rom a pivotal Phase 3 study of Ophena(TM),(ospemif...mptoms of,vulvovaginal atrophy, a common condition...
(Date:5/21/2008)...EIGHTS, N.J., May 21 /- Gen...ed that multiple abstracts,featuring its lead onco...meeting of the American Society of Clinical Oncolo...he abstracts include the following:, -- Initial ... G4544, an oral gallium-containing Compound. ...
Breaking Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 2CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 3CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 4CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 5CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation 6QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 3Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 2Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 1FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 4FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 5QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 1QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 2QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena 28TM 29 28ospemifene 29 to Treat Postmenopausal Vaginal Syndrome 1131 3Hookah Smoking as Tough on Lungs as Cigarettes 9019 1Hookah Smoking as Tough on Lungs as Cigarettes 9019 2Hookah Smoking as Tough on Lungs as Cigarettes 9019 3Novel anticancer strategy moves from laboratory to clinic 9014 1Novel anticancer strategy moves from laboratory to clinic 9014 2Novel anticancer strategy moves from laboratory to clinic 9014 3
Volk's super series slit lamp biomicroscopy lenses. General retinal scanning situations. Provide unprecedented fundus diagnostic capability, specifically addressing maximum potential field of view, f
Volk indirect lenses. High magnification views of the posterior pole.
Precision has its new line of programmable autoclaves which are easy to use bench-top autoclaves or models to fit any need. It has 4 adjustable sterilization programs, touch button control panel, man
...ina Tomograph is a confocal laser scanning microsc...nal images of the posterior segment. It enables th...y and precise follow-up of topographic changes. Th...eidelberg Retina Tomograph is the topographic desc...
Medicine Products: